Twist Bioscience Stock: Progress Hidden By Execution Issues And Soft Demand (NASDAQ:TWST)


DNA

ebrublue10

Twist Bioscience (NASDAQ:TWST) is slowly making progress in its core SynBio and NGS businesses, but its Biopharma business has execution issues and investment in data storage is being scaled back, potentially delaying commercialization. A greater focus on costs is leading to



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *